Showing results (181-190 of 211) with videos related to

Sort By:
Pageof 22
The European Respiratory Journal|September 2, 2005
Relationship between respiratory symptoms and medical treatment in exacerbations of COPDP Calverley, R Pauwels Dagger, C-G Löfdahl, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1994
Dystonia and dyskinesia in glutaric aciduria type I: clinical heterogeneity and therapeutic considerationsM Kyllerman, O H Skjeldal, M Lundberg, et al.
Scientific Reports|February 9, 2013
Extracting insights from the shape of complex data using topologyP Y Lum, G Singh, A Lehman, et al.
Molecular Pharmacology|April 26, 2005
Resveratrol inhibits angiotensin II- and epidermal growth factor-mediated Akt activation: role of Gab1 and Shp2Ursula G B Haider, Thomas U Roos, Maria I Kontaridis, et al.
Acta Oncologica (Stockholm, Sweden)|February 7, 2001
A pharmacokinetic study of 5-FU/leucovorin and alpha-interferon in advanced cancerP A Larsson, B Glimelius, B Jeppsson, et al.
Respiratory Medicine|August 21, 2012
Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroidsP M O'Byrne, S Rennard, H Gerstein, et al.
Scandinavian Journal of Rehabilitation Medicine|November 24, 1998
Relations between self-rated musculoskeletal symptoms and signs and psychological distress in chronic neck and shoulder painL E Dyrehag, E G Widerström-Noga, S G Carlsson, et al.
Investigative Ophthalmology & Visual Science|July 19, 2019
Oral Delivery of the P2Y12 Receptor Antagonist Ticagrelor Prevents Loss of Photoreceptors in an ABCA4-/- Mouse Model of Retinal DegenerationWennan Lu, Keith E Campagno, Huen-Yee Tso, et al.
Circulation. Arrhythmia and Electrophysiology|November 15, 2011
Reduced ventricular proarrhythmic potential of the novel combined ion-channel blocker AZD1305 versus dofetilide in dogs with remodeled heartsDaniel M Johnson, Monique M J de Jong, Harry J G M Crijns, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 1, 1986
Transmitter-replacement therapy in Alzheimer's disease using intracerebroventricular infusions of receptor agonistsS Gauthier, R Leblanc, Y Robitaille, et al.
Pageof 22